SE389331B - Forfarande for framstellning av vissa angivna 2,2-metylendifenoler. - Google Patents

Forfarande for framstellning av vissa angivna 2,2-metylendifenoler.

Info

Publication number
SE389331B
SE389331B SE7204544A SE454472A SE389331B SE 389331 B SE389331 B SE 389331B SE 7204544 A SE7204544 A SE 7204544A SE 454472 A SE454472 A SE 454472A SE 389331 B SE389331 B SE 389331B
Authority
SE
Sweden
Prior art keywords
methylendiphenols
procedure
preparation
certain stated
stated
Prior art date
Application number
SE7204544A
Other languages
English (en)
Inventor
Samuel Van Der Meer
Hendrikus Matheus Van Alphen
Original Assignee
Acf Chemiefarma Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acf Chemiefarma Nv filed Critical Acf Chemiefarma Nv
Publication of SE389331B publication Critical patent/SE389331B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/26—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups and being further substituted by halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SE7204544A 1971-04-09 1972-04-07 Forfarande for framstellning av vissa angivna 2,2-metylendifenoler. SE389331B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7104839.A NL167151C (nl) 1971-04-09 1971-04-09 Werkwijze ter bereiding van geneesmiddelen met anti-parasitaire werking op basis van halogeen bevatten- de 2,2'-methyleendifenolderivaten, alsmede werkwijze ter bereiding van deze geneeskrachtige verbindingen.

Publications (1)

Publication Number Publication Date
SE389331B true SE389331B (sv) 1976-11-01

Family

ID=19812895

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7204544A SE389331B (sv) 1971-04-09 1972-04-07 Forfarande for framstellning av vissa angivna 2,2-metylendifenoler.

Country Status (19)

Country Link
US (1) US3884906A (sv)
JP (2) JPS5525177B1 (sv)
AR (2) AR194587A1 (sv)
AU (1) AU459272B2 (sv)
BE (1) BE781674A (sv)
CH (2) CH575372A5 (sv)
DE (1) DE2215409C3 (sv)
DK (1) DK143227C (sv)
ES (1) ES401501A1 (sv)
FR (1) FR2132788B1 (sv)
GB (1) GB1346266A (sv)
HU (1) HU165790B (sv)
IE (1) IE36209B1 (sv)
IL (1) IL39108A (sv)
NL (1) NL167151C (sv)
PH (2) PH15268A (sv)
SE (1) SE389331B (sv)
SU (1) SU580828A3 (sv)
ZA (1) ZA722331B (sv)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4101678A (en) * 1977-11-08 1980-05-01 Ici Australia Ltd Process for killing parasites
FR2549476B1 (fr) * 1983-07-20 1986-04-25 Rech Ind Benzyl-phenyl-osides, procede de preparation et utilisation en therapeutique
US6403652B1 (en) 2000-06-30 2002-06-11 Colgate-Palmolive Company Method and composition
CA2557801C (en) * 2004-03-16 2013-06-25 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
UA91546C2 (uk) * 2005-05-03 2010-08-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
US7772191B2 (en) * 2005-05-10 2010-08-10 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
PE20080697A1 (es) * 2006-05-03 2008-08-05 Boehringer Ingelheim Int Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
CL2008002427A1 (es) * 2007-08-16 2009-09-11 Boehringer Ingelheim Int Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2.
EP2217602B1 (en) * 2007-11-30 2018-08-29 Boehringer Ingelheim International GmbH 1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-one derivatives and their use as pde9a modulators for the treatment of cns disorders
UA105362C2 (en) 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
PE20110383A1 (es) 2008-09-08 2011-07-15 Boehringer Ingelheim Int Pirazolopirimidinonas como inhibidores de la fosfodiesterasa 9a (pde9a)
HUE050287T2 (hu) 2009-02-13 2020-11-30 Boehringer Ingelheim Int SGLT2-inhibitort, DPP-IV-inhibitort és adott esetben egy további antidiabetikus hatóanyagot tartalmazó gyógyászati készítmény és alkalmazásai
EP4684831A3 (en) 2009-02-13 2026-03-11 Boehringer Ingelheim International GmbH Sglt2 inhibitor for improving glycemic control
CN102387783A (zh) * 2009-02-13 2012-03-21 贝林格尔.英格海姆国际有限公司 包含吡喃葡萄糖基二苯基甲烷衍生物的药物组合物、其药物剂型、其制备方法及其在患者中改善血糖控制的用途
CA2757231A1 (en) * 2009-03-31 2010-10-07 Boehringer Ingelheim International Gmbh 1-heterocyclyl-1,5-dihydro-pyrazolo [3,4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
AR077859A1 (es) * 2009-08-12 2011-09-28 Boehringer Ingelheim Int Compuestos para el tratamiento de trastornos del snc
BR112012007085B8 (pt) * 2009-09-30 2021-05-25 Boehringer Ingelheim Int processos para a preparação de derivados de benzil-benzeno substituídos com glicopiranosila
NZ598318A (en) * 2009-09-30 2014-02-28 Boehringer Ingelheim Int Method for the preparation of a crystalline form of 1-chloro-4- (beta-d-glucopyranos-1-yl)-2-(4-((s)-tetrahydrofuran-3-yloxy)benzyl)benzene
UY32919A (es) * 2009-10-02 2011-04-29 Boehringer Ingelheim Int Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos
CA2807687C (en) 2010-08-12 2019-01-08 Boehringer Ingelheim International Gmbh 6-cycloalkyl-1, 5-dihydro-pyrazolo [3,4-d] pyrimidin-4-one derivatives and their use as pde9a inhibitors
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
AR085689A1 (es) 2011-03-07 2013-10-23 Boehringer Ingelheim Int Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US9192617B2 (en) 2012-03-20 2015-11-24 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
TR201901110T4 (tr) 2013-04-05 2019-02-21 Boehringer Ingelheim Int Empagliflozinin terapötik kullanımları.
CA2812519A1 (en) 2013-04-05 2014-10-05 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US20140303097A1 (en) 2013-04-05 2014-10-09 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en) 2013-04-05 2023-11-14 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
HK1215378A1 (zh) 2013-04-18 2016-08-26 勃林格殷格翰国际有限公司 药物组合物、治疗方法及其用途
AU2017357589B2 (en) 2016-11-10 2023-05-11 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2544826A (en) * 1945-05-08 1951-03-13 Dow Chemical Co Anthelmintic feed composition
US2615052A (en) * 1950-06-23 1952-10-21 Allied Lab Inc 2,2'-methylenebis(4-chloro-6-nitrophenol) and a method for its production
US2739941A (en) * 1952-09-13 1956-03-27 Gen Aniline & Film Corp Germicidal soap composition
NL283922A (sv) * 1962-10-03

Also Published As

Publication number Publication date
CH575372A5 (sv) 1976-05-14
IL39108A0 (en) 1972-05-30
HU165790B (sv) 1974-11-28
NL7104839A (sv) 1972-10-11
FR2132788A1 (sv) 1972-11-24
IE36209L (en) 1972-10-09
AR193590A1 (es) 1973-04-30
PH14191A (en) 1981-03-26
NL167151B (nl) 1981-06-16
DK143227C (da) 1981-11-30
IE36209B1 (en) 1976-09-15
AR194587A1 (es) 1973-07-31
NL167151C (nl) 1981-11-16
DE2215409B2 (de) 1980-02-14
DE2215409A1 (de) 1973-01-25
DE2215409C3 (de) 1980-10-09
JPS5525177B1 (sv) 1980-07-04
US3884906A (en) 1975-05-20
ES401501A1 (es) 1975-02-16
ZA722331B (en) 1973-01-31
CH586182A5 (sv) 1977-03-31
AU4085072A (en) 1973-10-11
AU459272B2 (en) 1975-03-05
SU580828A3 (ru) 1977-11-15
DK143227B (da) 1981-07-27
GB1346266A (en) 1974-02-06
BE781674A (fr) 1972-10-05
JPS5950645B2 (ja) 1984-12-10
FR2132788B1 (sv) 1976-05-14
IL39108A (en) 1976-04-30
JPS557256A (en) 1980-01-19
PH15268A (en) 1982-11-02

Similar Documents

Publication Publication Date Title
SE389331B (sv) Forfarande for framstellning av vissa angivna 2,2-metylendifenoler.
SE384211B (sv) Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
FI55186B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara osymmetriska 1,4-dihydropyridinkarboxylsyraestrar
NO147916C (no) Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser.
BG20336A3 (bg) Метод за получаване на 3-карбомоил-2.4.6- трийдефинил-алкилетери
BG19375A3 (bg) Метод за получаване на 3,4-1н-изохиномин-1-они
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
SE386175B (sv) Forfarande for framstellning av 1,4-bis-acylpiperaziner
SE7505279L (sv) Forfarande for framstellning av hydroxipyrimidiner.
SE406587B (sv) Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin
NO137093C (no) Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner
SE394677B (sv) Forfarande for framstellning av 4-hydroxi-2h-1-bensotiopyran-3-karboxanilid-1,1-dioxider
SE390025B (sv) Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion
NO136046C (no) Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner.
SE383521B (sv) Forfarande for framstellning av kardenolid-3-(2',3-dedesoxi-2,'3'-oxido-glykosider).
SE400548B (sv) Forfarande for framstellning av en substituerad bensoylester av en 1,8,9-trihydroxiantracen
NO136195C (no) Fremgangsm}te ved fremstilling av 2,4-diamino-5-benzylpyrimidiner.
DK130308B (da) Fremgangsmåde til fremstilling af 13β-alkylgona-4,9,11-triener.
SE401366B (sv) Forfarande for framstellning av 2,6-metano-3-bensazociner
SE389103B (sv) Forfarande for framstellning av 1,4-metano-och 1,4-etanotetrahydro
SE389335B (sv) Forfarande for framstellning av vissa angivna ketaziner.
DK131189B (da) Analogifremgangsmåde til fremstilling af 16-hydroxylerede 17alfa-ethynyl-17beta-hydroxy-13beta-alkylgona-4,9,11-trien-3-oner.
NO138140C (no) Fremgangsmaate for fremstilling av 4,4`-ditert.butyl-benzoylperoksyd
DK134518B (da) Analogifremgangsmåde til fremstilling af 4beta-alkoxy-4alfa-(3'-hydroxyphenyl)-3alfa,5alfa-propanopiperidin-derivater.
NO137940C (no) Analogifremgangsmaate til fremstilling av 4`,5-dinitro-3`-trifluormetyl-2-tiofenanilid